chrX-2782104-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001141919.2(XG):āc.166C>Gā(p.Pro56Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,210,211 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 37 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001141919.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XG | NM_001141919.2 | c.166C>G | p.Pro56Ala | missense_variant | 4/11 | ENST00000644266.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XG | ENST00000644266.2 | c.166C>G | p.Pro56Ala | missense_variant | 4/11 | NM_001141919.2 | |||
XG | ENST00000381174.10 | c.166C>G | p.Pro56Ala | missense_variant | 4/10 | 1 | P1 | ||
XG | ENST00000419513.7 | c.100C>G | p.Pro34Ala | missense_variant | 2/9 | 1 | |||
XG | ENST00000509484.3 | c.100C>G | p.Pro34Ala | missense_variant | 2/8 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000116 AC: 13AN: 112258Hom.: 0 Cov.: 23 AF XY: 0.000174 AC XY: 6AN XY: 34400
GnomAD3 exomes AF: 0.0000654 AC: 12AN: 183442Hom.: 0 AF XY: 0.0000589 AC XY: 4AN XY: 67874
GnomAD4 exome AF: 0.000116 AC: 127AN: 1097953Hom.: 0 Cov.: 30 AF XY: 0.0000853 AC XY: 31AN XY: 363313
GnomAD4 genome AF: 0.000116 AC: 13AN: 112258Hom.: 0 Cov.: 23 AF XY: 0.000174 AC XY: 6AN XY: 34400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.166C>G (p.P56A) alteration is located in exon 4 (coding exon 4) of the XG gene. This alteration results from a C to G substitution at nucleotide position 166, causing the proline (P) at amino acid position 56 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at